18 completed. 18 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 18 |
| Phase 2 | 3 | Completed 3 |
Follow PATH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls Cecolin®, Gardasil® - Cervical Cancer | Phase 3 | Completed | PATH | 1025 | 2021-03-15 | 2025-01-30 |
| Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5) NmCV-5, Menactra - Meningococcal Meningitis | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1800 | 2019-08-20 | 2021-07-27 |
| Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants Pneumosil, Prevenar 13, Synflorix - Pneumonia, Pneumococcal | Phase 3 | Completed | PATH | 660 | 2019-07-18 | 2022-04-20 |
| Repeat Ivermectin Mass Drug Administrations for MALaria Control II Ivermectin, Placebo oral tablet - Malaria | Phase 3 | Completed | Brian Foy | 4124 | 2019-07-13 | 2025-04-10 |
| Phase III Study of Liquid Formulation of ROTAVIN ROTAVIN (liquid formulation), ROTAVIN-M1 (frozen formulation) - Diarrhea, Diarrhea Rotavirus | Phase 3 | Completed | Center for Research and Production of Vaccines and Biologicals, Vietnam | 825 | 2019-03-16 | 2021-01-25 |
| Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia ROTAVAC®, ROTAVAC 5D, Rotarix® - Diarrhea, Diarrhea Rotavirus | Phase 2 / Phase 3 | Completed | Centre for Infectious Disease Research in Zambia | 450 | 2019-01-22 | 2020-12-19 |
| Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants Pneumosil, Synflorix - Pneumonia, Pneumococcal | Phase 3 | Completed | PATH | 2250 | 2017-06-21 | 2020-07-14 |
| Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3 IVACFLU-S, Placebo - Influenza, Human | Phase 2 / Phase 3 | Completed | Institute of Vaccines and Medical Biologicals, Vietnam | 889 | 2017-03-20 | 2019-07-22 |
| A Safety and Immunogenicity Study of IVACFLU-A/H5N1 IVACFLU-A/H5N1 vaccine, Placebo - Avian Influenza | Phase 2 / Phase 3 | Completed | Institute of Vaccines and Medical Biologicals, Vietnam | 930 | 2017-03-07 | 2019-05-21 |
| Phase 3 Trial of Serbian Seasonal Influenza Vaccine Vaccine, Placebo - Influenza | Phase 3 | Completed | Institute of Virology, Vaccines and Sera, Torlak | 480 | 2016-11-28 | 2019-04-19 |
| Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization BRV-PV Lot A + DPT-HepB-Hib + OPV, BRV-PV Lot B + DPT-HepB-Hib + OPV, BRV-PV Lot C + DPT-HepB-Hib + OPV - Rotavirus Gastroenteritis | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1500 | 2015-11-01 | 2018-09-11 |
| Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine BBIBP Bivalent Oral Poliomyelitis Vaccine Lot 1, BBIBP Bivalent Oral Poliomyelitis Vaccine Lot 2, BioFarma Bivalent Oral Poliomyelitis Vaccine - Poliomyelitis | Phase 3 | Completed | PATH | 750 | 2015-08-01 | 2020-03-10 |
| A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV), Placebo - Rotavirus Gastroenteritis | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 7500 | 2014-05-01 | 2018-09-10 |
| Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal SIIL Live Attenuated Influenza Vaccine, Matched placebo - Influenza | Phase 3 | Completed | PATH | 1761 | 2013-05-01 | 2015-06-03 |
| A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh SIIL Live Attenuated Influenza Vaccine, Placebo - Influenza | Phase 3 | Completed | PATH | 1761 | 2013-02-01 | 2015-06-11 |
| Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine Live attenuated SA 14-14-2 vaccine - Encephalitis, Japanese B | Phase 3 | Completed | PATH | 519 | 2006-12-01 | 2014-10-13 |
| Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine Live Japanese encephalitis vaccine SA 14-14-2 (LJEV), Measles Vaccine (MV) - Encephalitis, Japanese B | Phase 3 | Completed | PATH | 600 | 2005-11-21 | 2020-03-10 |
| Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis Paromomycin sulfate, Amphotericin B - Visceral Leishmaniasis | Phase 3 | Completed | PATH | 667 | 2003-06-01 | 2014-10-03 |
Influenza, Human (4) · Diarrhea (2) · Encephalitis, Japanese (2) · Pneumonia, Pneumococcal (2) · Influenza in Birds (1) · Leishmaniasis, Visceral (1) · Malaria (1) · Meningitis, Meningococcal (1) · Poliomyelitis (1) · Uterine Cervical Neoplasms (1)
PHiD-CV vaccine (2) · RIX4414 vaccine (2) · 13-valent pneumococcal vaccine (1) · Amphotericin B (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Ivermectin (1) · Measles Vaccine (1) · Meningococcal Vaccines (1) · NmCV-5 vaccine (1) · Paromomycin (1) · Poliovirus Vaccine, Oral (1) · Vaccines (1)
India (3) · The Gambia (3) · Vietnam (3) · Bangladesh (2) · Philippines (2) · Burkina Faso (1) · Ghana (1) · Kenya (1) · Mali (1) · Senegal (1) · Serbia (1) · Zambia (1)
Niraj Rathi, MD (2) · Salvacion Gatchalian, MD (2) · Abdullah Brooks, MD, MPH (1) · Aldiouma Diallo, MD (1) · Brian D. Foy, PhD (1) · Dr Prasad Kulkarni, M.D. (1) · Dr. S.K. Bhattacharya (1) · Ed Clarke (1) · Ed Clarke, MB ChB, PhD (1) · Goran Stevanovic, MD (1) · Jessica Cowden, MD, MSPH (1) · Phan Cong Hung, MD (1) · Prasad Kulkarni, MD (1) · Prof C.P. Thakur (1) · Prof S. Sundar (1)
PMID 17582067, PMID 18394765, PMID 27746224, PMID 27746226, PMID 28967523, PMID 29028980, PMID 30104114, PMID 31070986, PMID 31812464, PMID 32518891, PMID 33516293, PMID 34218961, PMID 36638819, PMID 36939832, PMID 37224196, PMID 37256991, PMID 37256992, PMID 38431444, PMID 39919778, PMID 40120597, PMID 41276263
U01AI138910 (1)